ESC 2024 Insights
ESC 2024 Insights: Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia - AFLOAT
By
ESC 2024 Insights
FEATURING
Gilles Montalescot
By
ESC 2024 Insights
FEATURING
Gilles Montalescot
Login to view comments.
Click here to Login
